Insights into the 'dark zone'

November 26, 2015

B-cell lymphoma is one of the most common cancers derived from the lymphoid system. Lymphomagenesis is often linked to the so-called germinal center reaction. B lymphocytes represent a subgroup of the white blood cells, whose expansion after infection leads to germinal center formation. Within the germinal center, the 'light' zone selects the most highly functional germinal center B cells that have been generated in the 'dark' zone. This zoning leads to an efficient immune response. Klaus Rajewsky's group at the Max Delbrück Center for Molecular Medicine (MDC) in Berlin has now helped illuminate the processes within the dark zone. "The transcription factor FOXO1 was the main focus of our analyses," reports Sandrine Sander. She and her colleagues analyzed the impact of FOXO1 on B cells in the germinal center. "FOXO1 is a new key element for the formation of the dark zone and is thereby decisively involved in immune defense," emphasize Dr. Sander and Prof. Rajewsky, whose findings have been published in the current edition of Immunity.

The processes in the germinal center reaction are of interest for basic biomedical research also because their deregulation can lead to B cell tumors. In order to gain a better understanding of the pathological processes in the genesis of tumors, the scientists in Berlin investigated the germinal center reaction in genetically modified mice. The genetic modification allows for targeted influence on FOXO1 activity in germinal center B cells.

According to the new findings, FOXO1 is necessary not only for the formation of the germinal center dark zone but also for an efficient B cell response to pathogens.

The findings were corroborated in an independent study conducted by Riccardo Dalla-Favera's group working at Columbia University in New York in an article that appears in the same issue of Immunity.

However, the studies do not yet explain how FOXO1 and its activity relate to lymphomagenesis. What is clear is that this transcription factor plays an important role in the normal germinal center reaction and that additional studies are warranted, since most B cell lymphomas arise from germinal center B cells. Also, activating mutations of FOXO1 have been detected in lymphoma patients, which points to its clinical relevance.

Max Delbrück Center for Molecular Medicine in the Helmholtz Association

Related Molecular Medicine Articles from Brightsurf:

Two molecular handshakes for hearing
Scientists have mapped and simulated those filaments at the atomic level, a discovery that shed lights on how the inner ear works and that could help researchers learn more about how and why people lose the ability to hear.

Graduates of family medicine residencies are likely to enter and remain in family medicine
This study provides an overview of the characteristics of physicians who completed family medicine residency training from 1994 to 2017.

Nuclear medicine and COVID-19: New content from The Journal of Nuclear Medicine
In one of five new COVID-19-related articles and commentaries published in the June issue of The Journal of Nuclear Medicine, Johnese Spisso discusses how the UCLA Hospital System has dealt with the pandemic.

Stanford Medicine study details molecular effects of exercise
A simple blood test may be able to determine how physically fit you are, according to a new study conducted by scientists at the Stanford University School of Medicine.

Breakthrough in molecular machines
Molecular machines have the potential to revolutionize the future -- if we can find a way to control them.

NUS Medicine researchers can reprogramme cells to original state for regenerative medicine
Scientists from NUS Medicine have found a way to induce totipotency in embryonic cells that have already matured into pluripotency.

Molecular big data, a new weapon for medicine
Being able to visualize the transmission of a virus in real-time during an outbreak, or to better adapt cancer treatment on the basis of the mutations present in a tumor's individual cells are only two examples of what molecular Big Data can bring to medicine and health globally.

A molecular 'Trojan Horse'
The research group of Nuno Maulide from the Faculty of Chemistry of the University of Vienna has achieved the synthesis of a potential immunosuppressive agent by modification of a naturally occurring compound.

Creating new molecular sieves
Molecular sieves are useful in many industrial processes, especially in the chemical and energy sectors.

The ABS of molecular engines
Peroxisomes are cell organelles that carry out a number of functions, including the degradation of cytotoxins.

Read More: Molecular Medicine News and Molecular Medicine Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to